# Cadrenal Therapeutics, Inc.: Form SCHEDULE 13D, filed Jan 29, 2025

- Company: [Cadrenal Therapeutics, Inc.](/companies/cvkd.md) (CIK 1937993)
- Form: SCHEDULE 13D
- Filed: 2025-01-29
- Accepted by EDGAR: Jan 30, 2025, 00:29 ET
- Period: not reported
- Accession: 0001213900-25-007997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1937993/000121390025007997/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1937993/000121390025007997/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1937993/000121390025007997/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-007997. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.